Tabelecleucel
- Status:
- Do Not Prescribe (DNP)
- Decision Date:
- February 2022
Comments
DNP: NICE TA923 - Tabelecleucel
for treating post-transplant lymphoproliferative disorder caused by the Epstein-Barr virus. NHSE commissioned. Terminated appraisal. (Date November 2023)search again
